Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT 201 versus placebo for lateral periorbital wrinkles
2006-005396-17Phase 3Completed
- Sponsor
- Merz
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in lateral canthal rhytides and periocular rhytides (3 arms), sponsored by Merz. Primary endpoints: Primary efficacy endpoint and Application scheme comparison objective. Started Feb 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
lateral canthal rhytidesperiocular rhytides
Beyond the preview
Go deeper on 2006-005396-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005396-17.